Bacil Pharma Ltd
| Particulars | Mar 2026 | Dec 2025 | Sep 2025 |
|---|---|---|---|
| Revenue | 0.11 | 0.06 | 0.05 |
| Operating Expense | 0.07 | 0.03 | 0.04 |
| Net Profit | 0.62 | 0.04 | 0.01 |
| Net Profit Margin | 563.64% | 66.67% | 20% |
| Earning Per Share | 0.44 | 0.03 | 0.01 |
| EBIDTA | 0.62 | 0.04 | 0.01 |
| Effective Tax Rate | 0% | 0% | 0% |
Particulars
Mar 2026
Revenue0.11
Operating Expense0.07
Net Profit0.62
Net Profit Margin563.64
Earning Per Share0.44
EBIDTA0.62
Effective Tax Rate0
